BG60249B2 - Thiazole compound for treatment of ulcers - Google Patents

Thiazole compound for treatment of ulcers

Info

Publication number
BG60249B2
BG60249B2 BG53730A BG5373081A BG60249B2 BG 60249 B2 BG60249 B2 BG 60249B2 BG 53730 A BG53730 A BG 53730A BG 5373081 A BG5373081 A BG 5373081A BG 60249 B2 BG60249 B2 BG 60249B2
Authority
BG
Bulgaria
Prior art keywords
ulcers
treatment
thiazole compound
compound
thiazole
Prior art date
Application number
BG53730A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG60249B1 (bg
Inventor
Richard Pioch
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22712591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG60249(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of BG60249B1 publication Critical patent/BG60249B1/bg
Publication of BG60249B2 publication Critical patent/BG60249B2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG53730A 1980-10-02 1981-10-02 Thiazole compound for treatment of ulcers BG60249B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/193,192 US4375547A (en) 1980-10-02 1980-10-02 N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Publications (2)

Publication Number Publication Date
BG60249B1 BG60249B1 (bg) 1994-03-24
BG60249B2 true BG60249B2 (en) 1994-03-24

Family

ID=22712591

Family Applications (1)

Application Number Title Priority Date Filing Date
BG53730A BG60249B2 (en) 1980-10-02 1981-10-02 Thiazole compound for treatment of ulcers

Country Status (36)

Country Link
US (1) US4375547A (no)
EP (1) EP0049618B1 (no)
JP (1) JPS5791980A (no)
KR (1) KR850001795B1 (no)
AR (1) AR241439A1 (no)
AU (1) AU542553B2 (no)
BG (1) BG60249B2 (no)
CA (1) CA1166248A (no)
CS (1) CS227015B2 (no)
CY (1) CY1351A (no)
DD (1) DD200371A5 (no)
DE (1) DE3171819D1 (no)
DK (2) DK164056C (no)
EG (1) EG15678A (no)
ES (2) ES8301950A1 (no)
FI (2) FI813058L (no)
GB (1) GB2084581B (no)
GR (1) GR75023B (no)
HK (1) HK15987A (no)
HU (1) HU188697B (no)
IE (1) IE51603B1 (no)
IL (1) IL63980A (no)
LU (1) LU88293I2 (no)
MX (1) MX5723A (no)
MY (1) MY8700247A (no)
NL (1) NL930107I2 (no)
NO (1) NO155885C (no)
NZ (1) NZ198523A (no)
PH (1) PH18135A (no)
PL (2) PL130526B1 (no)
PT (1) PT73757B (no)
RO (2) RO85815B (no)
SU (1) SU1184443A3 (no)
UA (1) UA6081A1 (no)
YU (1) YU42728B (no)
ZA (1) ZA816817B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions
US4474794A (en) * 1982-03-19 1984-10-02 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
FR2531703A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa 2-aza-5-thiahexan-1-ones 1,6-disubstituees, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
FI840474A (fi) * 1983-02-07 1984-08-08 Lilly Co Eli Foerbaettringar vid syntes av nizatidin samt foerbaettringar beroerande denna.
US4468517A (en) * 1983-05-12 1984-08-28 Eli Lilly And Company Synthesis of thiazoles
DE3417127A1 (de) * 1984-05-09 1985-11-14 Papst-Motoren GmbH & Co KG, 7742 St Georgen Kleinstventilator
DE3531504A1 (de) * 1985-09-04 1987-03-12 Basf Ag 3-aminomethylpyrrol-1-yl-alkylamine und diese verbindungen enthaltende therapeutische mittel
CA1277325C (en) * 1985-12-18 1990-12-04 Bruce A. Slomski Synthesis of nizatidine
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
EP0285681B1 (de) * 1987-04-06 1993-03-10 HEUMANN PHARMA GMBH & CO Verfahren zur Herstellung von Nitroethenderivaten
ES2007959A6 (es) * 1988-07-11 1989-07-01 Vinas Lab Procedimiento para la obtencion de derivados tiazolicos.
DK0515121T3 (da) * 1991-05-21 2000-11-27 Lilly Co Eli Fremgangsmåde til fremstilling af mellemprodukter for nizatidin og beslægtede forbindelser
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5574054A (en) * 1992-05-12 1996-11-12 Zeria Pharmaceutical Co., Ltd. Quaternary ammonium salts and use thereof as medicine
US5541335A (en) * 1994-07-11 1996-07-30 Torcan Chemical Ltd. Process for preparing nizatidine
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition
CN1073095C (zh) * 1996-09-11 2001-10-17 克诺尔有限公司 尼扎替丁的制备方法
IT1299198B1 (it) 1998-03-05 2000-02-29 Nicox Sa Sali nitrati di farmaci antiulcera
CA2349575A1 (en) 1998-11-17 2000-05-25 Nitromed, Inc. Nitrosated and nitrosylated h2 receptor antagonist compounds, compositions and methods of use
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1750674A4 (en) * 2004-05-27 2012-05-23 Advanced Bionutrition Corp MICROPARTICLES FOR THE ORAL LEVY
WO2006071659A1 (en) * 2004-12-29 2006-07-06 Trustees Of Boston University Delivery of h2 antagonists
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US20090275622A1 (en) * 2008-04-30 2009-11-05 Prasoona Linga Nizatidine formulations
EP3167876B1 (en) 2012-03-15 2021-09-08 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
CN113181110A (zh) 2013-07-19 2021-07-30 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
BR112016011111B1 (pt) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
EP2942058A1 (en) 2014-05-09 2015-11-11 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and H2-receptor antagonists
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3917593A (en) * 1972-05-22 1975-11-04 Smithkline Corp N-alkenyl and N-alkynyl (2-quinolyl)thio-acetamides
US3853865A (en) * 1972-06-26 1974-12-10 Smithkline Corp N-aminomethyl-2-amino(and 2-amino-methyl)-2-heterocyclic-thioacetamides
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4191769A (en) * 1974-03-12 1980-03-04 Smith Kline & French Laboratories Limited Isothiourea compounds and pharmacological use
US4061637A (en) * 1974-05-14 1977-12-06 Istituto Luso Farmaco D'italia S.R.L. Certain 4-aryl-5-(4-phenylpiperazino)alkyl-4-thiazolin-2-ones
US4173644A (en) * 1975-02-03 1979-11-06 Smith Kline & French Laboratories Limited Thiourea compounds, compositions and methods and use
US4166856A (en) * 1975-05-21 1979-09-04 Smith Kline & French Laboratories Limited Thiazole and isothiazole derivative as blockers of histamine H2 -receptors
GB1574214A (en) * 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
GB1602458A (en) * 1977-05-05 1981-11-11 Smith Kline French Lab Bisamidines as histamine h2-antagonists
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
US4210658A (en) * 1977-09-08 1980-07-01 Smith Kline & French Laboratories Limited Amidinosulphonic acid derivatives
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
EP0006679B1 (en) * 1978-05-24 1982-07-21 Imperial Chemical Industries Plc Antisecretory thiadiazole derivatives, processes for their manufacture and pharmaceutical compositions containing them
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives

Also Published As

Publication number Publication date
IE51603B1 (en) 1987-01-21
AU542553B2 (en) 1985-02-28
KR850001795B1 (ko) 1985-12-21
ZA816817B (en) 1983-05-25
RO82215B (ro) 1983-06-30
US4375547A (en) 1983-03-01
DE3171819D1 (en) 1985-09-19
YU236481A (en) 1983-10-31
BG60249B1 (bg) 1994-03-24
FI813058L (fi) 1982-04-03
IE812285L (en) 1982-04-02
PH18135A (en) 1985-04-03
PL130626B1 (en) 1984-08-31
DK12391D0 (da) 1991-01-24
RO82215A (ro) 1983-07-07
CS227015B2 (en) 1984-04-16
CY1351A (en) 1987-04-24
NL930107I2 (nl) 1997-02-03
NO155885B (no) 1987-03-09
SU1184443A3 (ru) 1985-10-07
ES505950A0 (es) 1983-01-01
ES514868A0 (es) 1983-05-01
PT73757A (en) 1981-11-01
PL130526B1 (en) 1984-08-31
LU88293I2 (fr) 1994-05-04
UA6081A1 (uk) 1994-12-29
DK164056B (da) 1992-05-04
DD200371A5 (de) 1983-04-20
EP0049618B1 (en) 1985-08-14
PL233295A1 (no) 1982-12-20
HK15987A (en) 1987-02-27
MY8700247A (en) 1987-12-31
AU7594581A (en) 1982-04-08
RO85815B (ro) 1984-11-30
NL930107I1 (nl) 1993-10-18
YU42728B (en) 1988-12-31
JPH021141B2 (no) 1990-01-10
DK12391A (da) 1991-01-24
DK167759B1 (da) 1993-12-13
GB2084581B (en) 1985-02-27
GR75023B (no) 1984-07-12
DK435181A (da) 1982-05-12
IL63980A (en) 1986-04-29
CA1166248A (en) 1984-04-24
ES8301950A1 (es) 1983-01-01
GB2084581A (en) 1982-04-15
DK164056C (da) 1992-09-28
NO813334L (no) 1982-04-05
PL238035A1 (en) 1983-02-28
ES8306135A1 (es) 1983-05-01
FI76570B (fi) 1988-07-29
FI76570C (fi) 1988-11-10
EP0049618A1 (en) 1982-04-14
RO85815A (ro) 1984-11-25
KR830007602A (ko) 1983-11-04
MX5723A (es) 1993-12-01
IL63980A0 (en) 1982-01-31
EG15678A (en) 1986-12-30
PT73757B (en) 1983-01-13
JPS5791980A (en) 1982-06-08
NZ198523A (en) 1985-12-13
AR241439A1 (es) 1992-07-31
HU188697B (en) 1986-05-28
NO155885C (no) 1987-06-17

Similar Documents

Publication Publication Date Title
BG60249B2 (en) Thiazole compound for treatment of ulcers
IT8222608A0 (it) Procedimento per l'espossidazione di composti olefinici.
IT1083151B (it) Procedimento d'idrocianazione di composti organici insaturi comportanti almeno un doppio etilenico
IT1113271B (it) Procedimento per l'isolamento di xilite
ES465384A1 (es) Procedimiento para la obtencion de ciclopentan-1-aminas
UA7228A1 (uk) Спосіб одержання похідних n-(4-індолілпіперідиноалкіл )бензімідазолону або їх солей з кислотами
MY102277A (en) Quinoline compounds
JO1704B1 (en) New potent compounds
ATE46501T1 (de) Abkoemmlinge der guanidinomethylbenzoesaeure.
IT1098840B (it) Procedimento per la produzione di 2-(3'-0 4'-amminofenil)-5 (06)-amminobenzimmidazoli
FR2372165A1 (no)
FR2360583A1 (fr) B-azolylcetones utiles comme fongicides
ES467069A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol
AP8800109A0 (en) "Heterocyclic insecticides".
OA07768A (fr) Dérivés d'anillines fongicides.
ATE162717T1 (de) Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten
BG42832A3 (en) Herbicide means and method for prevention of unwanted growth
IT7819788A0 (it) Procedimento per fabbricazione dicomposti eterociclici e di biotina
IT8420682A1 (it) "Procedimento per il trattamento di articoli di maglieria"
FR2367761A1 (fr) Derives piperidylideniques de benzo-xanthenes,
FR2499815B1 (fr) Combinaison d'instruments pour travaux agricoles
IT8048641A0 (it) Procedimento di depurazione dell'antibiotico spectinomicina
BG31379A3 (en) Method for cephalosporine obtaining
IT1199114B (it) Composto farmaceutico a base di dii droergotossina per il trattamento dell'ipertensione
IT1171380B (it) Procedimento per l'inibizione della crescita dei protozoi